ICE vs MCO vs CME
161 measures in 16 categories, one definition each, computed from filings and market data.
ICE58.6
Intercontinental Exchange, Inc.
Financial Services · Financial - Data & Stock Exchanges
$161.56 +1.99%$90.7B mkt cap
Score DNA
MCO79.1
Moody's Corporation
Financial Services · Financial - Data & Stock Exchanges
$485.07 +0.30%$84.0B mkt cap
Score DNA
CME56.5
CME Group Inc.
Financial Services · Financial - Data & Stock Exchanges
$293.87 +1.52%$105.7B mkt cap
Score DNA
Price, rebased to 100 three years ago
ICE MCO CME · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 3 |
| Insider $ bought, 180d | — | — | $0.16M |
| Congress purchases, 180d | 3 | 0 | 0 |
| Last Congress purchase | 2026-07-07 | — | — |
| 13F net change in holders | −57 | — | −90 |
| ETFs adding shares, 30d | 1,303 | 1,191 | 1,338 |
| ETFs trimming, 30d | 1,144 | 1,062 | 1,135 |
| Net ETF funds, 30d | +159 | +129 | +203 |
Valuation
16 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| P/E (TTM) | 22.5x
44th
|
30.1x
89th
|
24.7x
56th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.68
22nd
|
1.11
44th
|
1.98
78th
|
| Price / sales | 7.3x
40th
|
10.3x
70th
|
15.6x
100th
|
| Price / book | 3.1x
11th
|
27.8x
100th
|
4.0x
44th
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 18.7x
40th
|
24.7x
70th
|
25.1x
80th
|
| Price / operating cash flow | 16.4x
30th
|
25.3x
90th
|
24.5x
80th
|
| Enterprise value | $109.3B
90th
|
$90.0B
70th
|
$106.8B
80th
|
| EV / sales | 8.8x
60th
|
11.0x
80th
|
15.8x
100th
|
| EV / EBITDA | 16.3x
33rd
|
22.5x
78th
|
19.5x
67th
|
| EV / EBIT | 21.2x
56th
|
25.7x
78th
|
20.5x
44th
|
| EV / free cash flow | 22.5x
40th
|
26.5x
80th
|
25.4x
70th
|
| Earnings yield | 4.4%
60th
|
3.3%
20th
|
4.0%
50th
|
| FCF yield | 5.3%
60th
|
4.0%
30th
|
4.0%
20th
|
| Operating cash flow yield | 6.1%
70th
|
4.0%
10th
|
4.1%
20th
|
| Graham number (per share) | $91.42
62nd
|
$78.41
38th
|
$139.38
88th
|
Profitability (TTM)
12 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| Gross margin | 79.0%
80th
|
71.9%
60th
|
81.9%
90th
|
| EBITDA margin | 53.7%
80th
|
49.0%
60th
|
80.9%
100th
|
| Operating margin | 43.5%
60th
|
45.1%
70th
|
65.1%
100th
|
| EBIT margin | 41.3%
60th
|
43.0%
70th
|
76.8%
100th
|
| Net margin | 32.3%
60th
|
34.3%
70th
|
63.1%
100th
|
| NOPAT margin | 33.4%
60th
|
35.1%
70th
|
49.7%
100th
|
| FCF margin | 38.8%
50th
|
41.6%
60th
|
62.2%
100th
|
| Operating cash flow margin | 44.2%
60th
|
40.7%
50th
|
63.6%
100th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 25.6%
70th
|
22.8%
60th
|
2.1%
0th
|
| Stock comp / revenue | 2.1%
40th
|
3.6%
80th
|
1.5%
20th
|
| Effective tax rate | 23.4%
70th
|
22.2%
50th
|
23.6%
80th
|
Returns on capital
11 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| ROE (on average equity) | 13.9%
11th
|
80.2%
100th
|
15.7%
33rd
|
| ROA | 2.5%
20th
|
18.5%
90th
|
2.3%
10th
|
| ROIC | 8.7%
10th
|
31.6%
90th
|
12.2%
50th
|
| ROCE | 9.6%
20th
|
30.9%
90th
|
14.5%
60th
|
| Return on tangible assets | 3.2%
30th
|
23.2%
90th
|
2.8%
20th
|
| Cash ROIC (OCF / invested capital) | 11.5%
10th
|
36.7%
80th
|
15.6%
40th
|
| Gross profitability (GP / assets) | 5.7%
10th
|
40.0%
80th
|
2.8%
0th
|
| ROIC, 3-yr average | 6.0%
10th
|
21.5%
70th
|
10.3%
40th
|
| ROIC, 5-yr average | 7.0%
0th
|
22.7%
78th
|
11.4%
44th
|
| ROE, 5-yr average | 10.9%
22nd
|
63.2%
100th
|
12.6%
44th
|
| Incremental ROIC | 94.7%
80th
|
-176.1%
20th
|
-41.1%
50th
|
Growth
17 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| Revenue growth (TTM YoY) | -0.6%
20th
|
11.7%
90th
|
5.1%
30th
|
| Revenue growth (QoQ) | -27.3%
0th
|
5.1%
80th
|
-9.2%
20th
|
| Revenue CAGR, 3 yr | 9.2%
30th
|
13.9%
90th
|
8.9%
20th
|
| Revenue CAGR, 5 yr | 7.4%
20th
|
7.1%
10th
|
8.0%
40th
|
| Gross profit CAGR, 3 yr | 23.1%
80th
|
18.6%
70th
|
7.7%
30th
|
| Operating income CAGR, 3 yr | 13.7%
44th
|
24.0%
78th
|
11.7%
22nd
|
| Net income growth (TTM YoY) | 34.1%
89th
|
31.1%
78th
|
13.7%
33rd
|
| Net income CAGR, 3 yr | 33.6%
78th
|
25.1%
56th
|
12.8%
22nd
|
| EPS growth (TTM YoY) | 36.2%
89th
|
34.5%
78th
|
13.1%
22nd
|
| EPS CAGR, 3 yr | 33.2%
78th
|
27.0%
56th
|
12.5%
22nd
|
| EPS CAGR, 5 yr | 7.4%
22nd
|
7.4%
11th
|
17.1%
89th
|
| FCF growth (TTM YoY) | 10.8%
50th
|
43.3%
80th
|
2.6%
20th
|
| FCF CAGR, 3 yr | 15.4%
60th
|
27.3%
90th
|
10.7%
40th
|
| Operating cash flow CAGR, 3 yr | 14.9%
60th
|
19.9%
80th
|
10.5%
40th
|
| Book value CAGR, 3 yr | 7.1%
56th
|
0.2%
33rd
|
-1.8%
11th
|
| Dividend CAGR, 3 yr | 1.7%
25th
|
2.7%
38th
|
1.6%
12th
|
| Sustainable growth rate | 10.0%
25th
|
60.1%
100th
|
0.7%
0th
|
Margin history & stability
7 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| Gross margin, 3-yr average | 63.7%
50th
|
68.4%
60th
|
84.7%
100th
|
| Operating margin, 3-yr average | 39.0%
60th
|
42.9%
80th
|
64.4%
100th
|
| Net margin, 3-yr average | 25.9%
50th
|
30.6%
70th
|
59.4%
100th
|
| FCF margin, 3-yr average | 34.9%
50th
|
35.3%
60th
|
62.1%
100th
|
| Revenue stability (0-1) | 0.91
30th
|
0.78
10th
|
0.98
60th
|
| Earnings stability (0-1) | 0.13
20th
|
0.35
30th
|
0.94
90th
|
| Margin stability (0-1) | 0.82
10th
|
0.95
50th
|
0.97
90th
|
Liquidity (latest quarter)
7 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| Cash & short-term investments | $2.0B
60th
|
$1.5B
50th
|
$2.3B
70th
|
| Net cash (− = net debt) | −$18.6B
0th
|
−$6.0B
40th
|
−$1.1B
80th
|
| Working capital | $1.5B
80th
|
$637.0M
60th
|
$2.8B
90th
|
| Current ratio | 1.01
40th
|
1.19
70th
|
1.02
50th
|
| Quick ratio | 0.04
0th
|
1.19
70th
|
1.02
50th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.02
10th
|
0.45
40th
|
0.01
0th
|
| Defensive interval (days) | 315 days
0th
|
569 days
50th
|
972 days
90th
|
Leverage & solvency (latest quarter)
13 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| Total debt | $20.5B
100th
|
$7.5B
70th
|
$3.4B
30th
|
| Debt / equity | 0.69
44th
|
2.49
100th
|
0.13
11th
|
| Net debt / equity | 0.63
56th
|
1.99
100th
|
0.04
22nd
|
| Debt / assets | 11.8%
20th
|
51.3%
90th
|
1.8%
10th
|
| Debt / capital | 41.0%
44th
|
71.3%
100th
|
11.4%
11th
|
| Debt / EBITDA | 3.07
78th
|
1.88
33rd
|
0.63
11th
|
| Net debt / EBITDA | 2.77
89th
|
1.51
44th
|
0.21
11th
|
| Interest coverage (EBIT / interest) | 6.6x
22nd
|
15.9x
78th
|
59.3x
100th
|
| Cash interest coverage | 7.1x
22nd
|
15.0x
67th
|
49.1x
100th
|
| Debt payback (years of OCF) | 3.7 yrs
70th
|
2.3 yrs
30th
|
0.8 yrs
10th
|
| Liabilities / assets | 83.0%
80th
|
78.4%
70th
|
86.4%
90th
|
| IS credit model rating | A | A+ | A+ |
| Implied credit spread (bps) | 150
50th
|
125
20th
|
125
20th
|
Efficiency
11 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| Asset turnover | 0.08
10th
|
0.54
70th
|
0.04
0th
|
| Fixed asset turnover | 4.33
0th
|
6.49
20th
|
19.28
90th
|
| Inventory turnover | 0.0 | — | — |
| Receivables turnover | 7.1
50th
|
4.4
10th
|
9.5
80th
|
| Days sales outstanding | 51 days
50th
|
83 days
90th
|
38 days
20th
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 155 days
100th
|
91 days
90th
|
24 days
30th
|
| Cash conversion cycle (days) | — | −8 days
11th
|
14 days
56th
|
| Capex / revenue | 5.3%
78th
|
— | 1.4%
44th
|
| Capex / depreciation | 0.43
56th
|
— | 0.35
44th
|
| Operating expense ratio | 47.8%
90th
|
28.4%
70th
|
4.4%
0th
|
Cash flow & earnings quality
7 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| Operating cash flow / net income | 1.37
78th
|
1.19
44th
|
1.01
11th
|
| FCF / net income | 1.20
78th
|
1.22
89th
|
0.99
22nd
|
| FCF / operating cash flow | 87.9%
44th
|
— | 97.8%
67th
|
| Capex / operating cash flow | 12.1%
56th
|
— | 2.2%
33rd
|
| Accruals ratio | -0.9%
80th
|
-3.5%
40th
|
-0.0%
90th
|
| Sloan accruals ratio | -0.4%
80th
|
-11.4%
20th
|
-0.0%
90th
|
| Earnings quality score (0-1) | 1.00
33rd
|
1.00
33rd
|
1.00
33rd
|
Scores & forensic checks
15 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| IS score | 59
20th
|
79
100th
|
56
10th
|
| IS profitability | 74
20th
|
99
100th
|
75
50th
|
| IS growth | 56
50th
|
74
100th
|
53
40th
|
| IS value | 58
80th
|
43
20th
|
56
60th
|
| IS momentum | 85
60th
|
90
90th
|
74
30th
|
| IS risk (safety) | 100
10th
|
100
10th
|
65
0th
|
| IS quality | 85
100th
|
75
30th
|
80
70th
|
| IS balance sheet | 42
10th
|
46
20th
|
60
80th
|
| IS earnings quality | 83
90th
|
68
20th
|
82
80th
|
| IS cash flow | 78
70th
|
86
100th
|
83
90th
|
| Piotroski F-score (0-9) | 8
80th
|
7
50th
|
6
30th
|
| Altman Z-score | — | — | — |
| Beneish M-score | — | — | — |
| Ohlson O-score | −6.99
70th
|
−7.17
60th
|
−6.77
80th
|
| IS credit score | 74
50th
|
78
70th
|
80
80th
|
Size (TTM)
8 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| Market cap | $90.7B
80th
|
$84.0B
70th
|
$105.7B
90th
|
| Revenue | $12.5B
90th
|
$8.2B
70th
|
$6.8B
60th
|
| EBITDA | $6.7B
90th
|
$4.0B
70th
|
$5.5B
80th
|
| Net income | $4.0B
80th
|
$2.8B
70th
|
$4.3B
90th
|
| Free cash flow | $4.8B
90th
|
$3.4B
70th
|
$4.2B
80th
|
| Total assets | $174.2B
90th
|
$14.7B
50th
|
$194.7B
100th
|
| Shareholders' equity | $29.6B
90th
|
$3.0B
40th
|
$26.5B
80th
|
| Employees | 12,725
70th
|
16,000
90th
|
3,875
10th
|
Price performance
9 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| 1 day | +2.0% | +0.3% | +1.5% |
| 1 week | +3.4% | +4.5% | +4.7% |
| 1 month | +5.4% | +5.0% | +8.4% |
| 3 months | +14.1% | −4.0% | +19.9% |
| 6 months | +0.2% | +6.5% | +2.2% |
| Year to date | +1.0% | −2.6% | +9.0% |
| 1 year | +2.9% | +1.6% | +10.1% |
| 3 years, cumulative | +49.0% | +51.7% | +48.8% |
| 5 years, cumulative | +33.3% | +38.8% | +74.0% |
Technicals
4 measures| Measure | ICE | MCO | CME |
|---|---|---|---|
| RSI 14 | 64.0 | 60.8 | 71.4 |
| From 52-week high | −8.2% | −11.1% | −8.6% |
| From 52-week low | +32.7% | +20.9% | +34.6% |
| Beta | 0.94 | 1.35 | 0.27 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17